CRME Stock Analysis
CRME - CARDIOME PHARMA CORP listed on NASDAQ.
CRME - Sector: Healthcare, Industry: Biotechnology and Drugs.
CRME is currently in a downtrend.
CRME lost -1.00% on 10/31/14 and a total percentage of -1.85% in the past 3 day
CRME is trading in the range of $7.12 - $9.06 in the past 30 days.
Commodity Channel Index (CCI) is bullish for CRME.
Stock performance base on day of week in the past 90 days.
Our rating on the stock: NEUTRAL with a score of 3/5.
CRME Earnings Date